The Use of Glucose as Alternative Reducing Agent
Letters in Organic Chemistry, 2011, Vol. 8, No. 10
705
= 14.5 Hz); 13C NMR (CDCl3, 125 MHz) ꢀ 147.8, 132.9,
129.2, 128.9, 128.8, 128.7, 128.7, 128.1, 125.8, 119.8, 52.6.
MS [EI+] m/z (%) 468 [M]+ (40), 349 [M - C7H7N2]+ (35),
321 [M - C7H7N4]+ (35), 91 [C6H5CH2]+ (100).
144.9, 134.5, 129.9, 129.1, 128.8, 128.1, 122.4, 114.6, 62.2,
54.2, 20.4. MS [EI+] m/z (%) 279 [M]+ (40), 144 [M –
C7H7N2O]+ (70), 91 [C6H5CH2]+ (100). HRMS (EI+): for
C17H17N3O calcd. 279.1372, found 279.1377.
1-Benzyl-4-(4-methoxy-phenoxymethyl)-[1,2,3]triazole
(entry 2, Table 3)
Crystal data: formula: C17H17N3O; FW 279.34; crystal
system: Orthorhombic; space group: P212121; temp,
K=296(2); ꢀ, Å=1.54178; Unit cell dimensions a,
Å=5.7275(6); b, Å=8.1375(8); c, Å= 32.067(3); ꢁ, deg= 90;
ꢂ, deg= 90; ꢃ, deg= 90; V, Å3=1494.6(3); Z=4; ꢄcalcld., g·cm–
3=1.241; μ, mm–1=0.632; F(000)= 592; crystal size, mm3=0.2
x 0.05 x 0.05; ꢅ range for data collection, deg= 2.76 to
66.37; index ranges: – 6 ꢂ h ꢂ 5, – 9 ꢂ k ꢂ 9, – 37 ꢂ l ꢂ 38;
Reflections collected: 14063; Independent reflections (Rint)=
2582 (0.0287); no. of data / restraints / parameters=2582 / 0 /
190; GoF on F2=1.073; Final R indices [I>2ꢃ(I)] R1=0.0300,
wR2=, 0.0817; R1, wR2 (all data): 0.0303, 0.0820; largest diff.
peak / hole, e·Å–3=0.107 / –0.109.
m.p. 78°C (MeOH). IR (KBr, cm) ꢁ= 1508, 1458, 1228
1
cm-1. H-NMR (CDCl3, 300 MHz) ꢀ 7.49 (s, 1H), 7.33(m,
5H), 6.89 (d, 2H, J=8.5Hz), 6.78 (d, 2H, J=8.5Hz), 5.47 (s,
2H), 5.10 (s, 2H),3.76 (s, 3H). 13C-NMR (CDCl3, 75 MHz) ꢀ
ppm: 154.5, 154.2, 144.8, 129.1, 128.7, 128.0, 122.6, 116.1,
134.5, 115.9, 114.6, 62.8, 56.5, 55.5. MS [EI+] m/z (%): 295
[M]+ (20), 144 [M – C7H7N2O2]+ (35), 123 [M – C9H8N3]+
(100), 91 [C6H5CH2]+ (50). HRMS (EI+): for C17H17N3O2
calcd. 295.1321, found 295.1325.
4-(1-Benzyl-1H-[1,2,3]triazol-4-ylmethoxy)-benzaldehyde
(entry 3, Table 3)
In addition, the reaction afforded 3,3'-Dibenzyl-5,5'-bis-
p-tolyloxymethyl-3H,3'H-[4,4']bi[[1,2,3]triazolyl] as a White
solid (20%); 56-57°C (MeOH). IR (KBr): ꢁ = 1260, 1300,
White solid (80%); mp 79-80 °C (MeOH). IR (KBr): ꢁ=
1252, 1508, 1680 cm-1. 1H NMR (CDCl3, 500 MHz) ꢀ
9.89(s, 1H), 7.83 (d, 2H, J= 8 Hz), 7.80 (m, 2H), 7.58(s, 1H),
7.36 (m, 3H), 7.08(d, 2H, J= 8 Hz), 5.53 (s, 2H), 5.25 (s,
2H). 13C NMR (CDCl3, 125 MHz) ꢀ 190.7, 163.14, 163.1,
143.5, 134.3, 130.3, 129.1, 128.9, 128.0, 122.9, 115.1, 62.1,
55.9. MS [EI+] m/z 293 [M]+ (10), 172 [M - C7H9N2]+ (75),
144 [M – C7H7N2O]+ (80), 91 [C6H5CH2]+ (100). HRMS
(EI+): for C17H15N3O2 calcd. 293.1164, found 293.1165.
1
1560, 3125 cm-1. H NMR (CDCl3, 500 MHz) ꢀ 7.27 (m,
6H), 6.96 (d, 4H), 6.88 (d, 4H), 6.49 (m, 4H), 4.96 (d, 2H),
4.55 (d, 2H), 4.49 (d, 2H), 4.30 (d, 2H), 2.24 (s, 6H). 13C
NMR (CDCl3, 125 MHz) ꢀ 155.5, 146.0, 138.8, 130.6,
129.8, 129.0, 128.9, 128.1, 114.2, 60.9, 52.5, 20.4. [EI+] m/z
(%) 556 [M]+ (10), 91 [C6H5CH2]+ (100). HRMS (EI+): for
C34H32N6O2 calcd. 556.2587, found 556.2590.
1-Benzyl-4-(4-bromo-phenoxymethyl)-1H-[1,2,3]triazole
(entry 4, Table 3)
(1-Benzyl-1,2,3-triazol-4-yl)methyl butylcarbamate (entry 7,
Table 3)
White solid (53%); mp 109-111 °C(MeOH). IR (KBr):
White solid (43%); mp 82-83°C (MeOH). IR (KBr): ꢁ =
1536, 1610, 1710, 2954 cm-1. 1H NMR (CDCl3, 500 MHz) ꢀ
7.99 (s, 1H), 7.28-7.41 (m, 5H), 7.26 (s, 2H), 5.54 (s, 1H,
NH), 5.22 (s, 2H), 4.59 (s, 2H), 3.15 (m 2H),1.44 (m, 2H),
1.25 (m, 2H), 0.86 (t, 3H). 13C NMR (CDCl3, 125 MHz) ꢀ
156.2, 143.9, 134.6, 129.7, 128.5, 127.9, 120.4, 57.6, 52.9,
40.7, 31.9, 19.8, 13.7. MS [EI+] m/z (%) 288 [M]+ (10), 144
[M – C5H10N3O2]+ (20), 91 [C6H5CH2]+ (100). HRMS (EI+):
for C15H20N4O2 calcd. 288.1586, found 288.1583.
1
ꢁ= 1241, 1491, 1601, 3080, cm-1. H NMR (CDCl3, 500
MHz) ꢀ 7.52 (s, 1H), 7.37 (m, 2H), 7.28 (m, 2H), 7.19 (m,
1H), 6.93 (m, 2H), 6.84 (m, 2H), 5.54 (s, 2H), 5.16 (s, 2H).
13C NMR (CDCl3, 125 MHz) ꢀ 158.8, 144.0, 134.8, 134.3,
130.2, 129.1, 128.8, 128.1, 122.6, 121.4, 115.4, 113.1, 62.2,
54.2. MS [EI+] m/z 345 [M+2]+ (5), 343 [M]+ (5), 172 [M-
C6H4BrO]+ (15), 144 [M-C8H8BrO]+ (65), 91 [C6H5CH2]+
(100). HRMS (EI+): for C16H14BrN3O calcd. 343.0320,
found 343.0324.
(1-Benzyl-1H-[1,2,3]triazol-4-ylmethyl)-dibutyl-amine
(entry 8, Table 3)
1-benzyl-4-(4´-chlorophenoxymethyl)-1,2,3-triazole (entry
5, Table 3)
White solid (65%); mp 66-67°C °C (MeOH). IR (KBr): ꢁ
= 1577, 1473, 1276 cm-1. 1H NMR (CDCl3, 500 MHz) ꢀ 7.6
(s, 1H), 7.26-7.47 (m, 5H), 5.52 (s, 2H), 3.8 (s, 2H), 2.5 (s,
4H), 1.5 (m, 4H), 1.26 (m, 4H), 0.89 (t, 6H). 13C NMR
(CDCl3, 125 MHz) ꢀ 134.7, 132.4, 129.1, 129.0, 128.9,
127.9, 58.5, 54.1, 52.8, 27.9, 20.4,13.9. MS [EI+] m/z
(%)300 [M]+ (5), 257 [M-C3H7]+ (45), 144 [M-C10H21N]+
(45), 91 [M-C11H21N4]+ (100), 73 [M-C14H17N3]+ (65).
HRMS (EI+): for C18H28N4 calcd. 300.2314, found 300.2319.
White solid (82%); mp 102-103°C(MeOH). IR (KBr): ꢁ=
1241, 1491, 1599, 3083, cm-1. 1H NMR (CDCl3, 500 MHz) ꢀ
7.52 (s, 1H), 7.37 (m, 2H), 7.28 (m, 2H), 7.19 (m, 1H), 6.93
(m, 2H), 6.84 (m, 2H), 5.54 (s, 2H), 5.16 (s, 2H), 13C NMR
(CDCl3, 125 MHz) ꢀ 158.8, 144.0, 134.8, 134.3, 130.2,
129.1, 128.8, 128.1, 122.6, 121.4, 115.4, 113.1, 62.2, 54.2.
MS [EI+] m/z (%) 301 [M +2]+ (5), 299 [M]+ (15), 144 [M –
C6H4ClN2O]+ (50), 91 [C6H5CH2]+ (100). HRMS (EI+): for
C16H14ClN3O calcd. 299.0825, found 299.0827.
(1-Benzyl-[1,2,3]triazol-4-yl)-methanol (entry 9, Table 3)
1-Benzyl-4-p-tolyloxymethyl-[1,2,3]triazole (entry 6, Table
3)
White solid (73%); mp 76-77°C (lit. 76-77°C);10 IR
1
(KBr): ꢁ = 1276, 1475, 1572, 3330 cm-1 . H NMR (CDCl3,
White solid (75%); mp 92-93°C (MeOH). IR (KBr): ꢁ =
1572, 1475, 1276 cm-1. 1H NMR (CDCl3, 500 MHz) ꢀ
7.51(s, 1H), 7.36 (d, 2H, J=8 Hz), 7.26 (d, 2H, J=8 Hz), 7.06
(d, 2H, J=8 Hz), 6.84 (d, 2H, J=8 Hz), 5.52(s, 2H), 5.15 (s,
2H), 2.27 (s, 3H). 13C NMR (CDCl3, 125 MHz) ꢀ 156.1,
500 MHz) ꢀ 7.47(s, 1H), 7.32 (m, 3H), 7.21 (m, 2H), 5.44(s,
2H), 4.68 (s, 2H). 13C NMR (CDCl3, 125 MHz) ꢀ 148.3,
134.5, 129.0, 128.7, 128.0, 121.9, 55.9, 54.0. MS [EI+] m/z
(%) 189 [M]+ (40), 91 [C6H5CH2]+ (100).